Literature DB >> 8001482

Biliary stenting in benign biliary stenosis complicating chronic calcifying pancreatitis.

M Barthet, J P Bernard, J L Duval, C Affriat, J Sahel.   

Abstract

This a retrospective study of 19 patients presenting with chronic pancreatitis and benign stenosis of the common bile duct, who were followed up for periods ranging from 13 months to 48 months after biliary stenting (average 18 months). There were 18 men and one woman, aged between 38 and 65 years (average 49 years). The mean duration of the disease before stenting was seven years (range 1-25 years). Symptoms were present in ten patients: obstructive jaundice in four cases, cholangitis in three cases, and biliary colic in three cases. Nine patients without clinical complaints presented with chronic cholestasis. Endoscopic retrograde cholangiopancreatography (ERCP) showed 15 long, regular stenoses of the intrapancreatic course of the common bile duct, three short stenoses located at the upper margin of the head of the pancreas, and one biliary stenosis associated with peripheral compression by a cyst of the head of the pancreas. Forty endoscopic biliary stenting procedures were performed in the 19 patients over a six-year period. Successful insertion of the prosthesis was achieved in 39 cases. Two complications occurred: one duodenal ulceration and one stent migration into the bile duct. The mean duration of biliary stenting was ten months. Only two patients (10%) had complete clinical, biological, and radiological recovery. Complete failure of biliary stenting was observed in six patients (31%). Eleven patients (59%) had partial results: six (31%) had biological improvement although the biliary stricture persisted, and five were clinically asymptomatic but had cholestasis, and still presented with biliary stenosis in four cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8001482     DOI: 10.1055/s-2007-1009041

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  21 in total

1.  Surgical Management of Benign Biliary Stricture in Chronic Pancreatitis: A Single-Center Experience.

Authors:  Sukanta Ray; Supriyo Ghatak; Khaunish Das; Jayanta Dasgupta; Sujay Ray; Sujan Khamrui; Pankaj Kumar Sonar; Somak Das
Journal:  Indian J Surg       Date:  2013-07-11       Impact factor: 0.656

2.  What is the role of endotherapy in chronic pancreatitis?

Authors:  Haritha Avula; Stuart Sherman
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

3.  Benign biliary strictures related to chronic pancreatitis: balloons, stents, or surgery.

Authors:  Sami Arslanlar; Rajeev Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2007-10

Review 4.  Endoscopic therapy of benign biliary strictures.

Authors:  Joel R Judah; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

5.  Biliary tract obstruction in chronic pancreatitis.

Authors:  Abdul A Abdallah; Jake E J Krige; Philippus C Bornman
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 6.  Benign biliary strictures: current endoscopic management.

Authors:  Sergio Zepeda-Gómez; Todd H Baron
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-09-06       Impact factor: 46.802

Review 7.  Endoscopic management of benign biliary strictures.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Curr Gastroenterol Rep       Date:  2015-01

8.  Long-term follow-up after bilioenteric anastomosis for benign bile duct stricture.

Authors:  W H Nealon; F Urrutia
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

Review 9.  Endoscopic therapy for chronic pancreatitis: an evidence-based review.

Authors:  C Mel Wilcox; Shyam Varadarajulu
Journal:  Curr Gastroenterol Rep       Date:  2006-04

Review 10.  Plastic or metal stents for benign extrahepatic biliary strictures: a systematic review.

Authors:  Petra G A van Boeckel; Frank P Vleggaar; Peter D Siersema
Journal:  BMC Gastroenterol       Date:  2009-12-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.